Name: Net Profit Margin

Definition: Net profit margin shows how much profit remains after paying all costs — including operating expenses, interest, and taxes — for every dollar of sales. A higher margin means the business is efficient and keeps more of its sales as bottom-line profit. Falling margins may signal rising costs or pricing pressure.

Interpretation:
• In '2021', IMTX's net profit margin was -268.5%, measuring the overall profitability of the company. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2021' stood at -219.6%.
• In '2022', IMTX's net profit margin was 16.0%, measuring the overall profitability of the company. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2022' stood at -250.0%. Industry average declined by 30.4% from previous year.
• In '2023', IMTX's net profit margin was -175.3%, measuring the overall profitability of the company. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2023' stood at -210.5%. Industry average increased by 39.5% compared to previous year.
• In '2024', IMTX's net profit margin was 9.8%, measuring the overall profitability of the company. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2024' stood at -164.8%. Industry average increased by 45.7% compared to previous year.
Overall, IMTX's net profit margin has been volatile but showed an upward trend over the past 4 years.

Formula: Net Profit Margin = Net Income / Revenue

Good Range: Ranges 5%-20% for many industries.